Upcoming Events

Subscribe to our mailing list to stay up to date on upcoming events.



Understanding New Changes to the OVA1 Results Report

November 3, 3016

East Coast: 12:30-12:45 p.m. EST

West Coast: 12:30-12:45 p.m. PST

Presented by: Dr. Marra Francis, Chief Medical Officer of Vermillion and Dr. Herb Fritsche, Lab Director of ASPiRA Labs

Register for East Coast, here.

Register for West Coast, here.

Third Quarter 2016 Financial Results and Investor Conference Call

November 10, 2016 at 4:30 p.m. EST

Join by phone:

  • Domestic: 1-888-296-4197
  • International: 1-719-2462
  • Conference ID: 6709878

Join by webcast, here.

Replay dial-in numbers (available through): November 24, 2016

  • Domestic: 1-844-512-2921
  • International: 1-412-317-6671
  • Replay PIN: 6709878

AAGL 45th Annual Global Congress

November 14-18, 2016

The Rosen Hotel

Orlando, Florida

Canaccord Tenuity, Medical Technologies & Diagnostics Forum

November 17, 2016

Westin Grand Central Hotel

New York, New York

Learn about what is new with OVA1 – May 6-9, 2017, San Diego, California

Visit ACOG Booth#830 to Learn more about what is new with OVA1.

2017 ACOG Annual Clinical and Scientific Meeting

May 6-9, 2017, San Diego, California

The American College of Obstetricians and Gynecologists invites you to San Diego, CA, May 6-9, 2017, to help prepare the Next Generation of Health Care for challenges ahead. This annual gathering of leading women’s health care experts in sunny California will deliver the latest scientific information to benefit your patients and provide leadership in our changing industry.

For Investors

A Vermillion Investor Overview

We are dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women.